`Alzheimer`s drug to be developed within five years`
Washington: Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.
Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.
In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.
Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.
Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.
More from India
More from World
More from Sports
More from Entertaiment
- 'Baahubali' becomes first non-Hindi film to cross Rs 500 crore
- Washington Mayor calls Michelle Obama 'gorilla face', says 'she is attractive only to monkey man Barack'
- 'Bajrangi Bhaijaan' impact: Govt agrees to help deaf-and-dumb Indian girl stranded in Pakistan
- Ban on internet porn: Here's why it is impossible
- Govt doesn't want you to even watch porn in private, blocks over 800 sites